Waters Corporation
$ 326.30
-0.45%
24 Feb - close price
- Market Cap 32,006,611,000 USD
- Current Price $ 326.30
- High / Low $ 331.97 / 321.99
- Stock P/E 30.50
- Book Value 43.01
- EPS 10.70
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.12 %
- ROE 0.29 %
- 52 Week High 414.15
- 52 Week Low 275.05
About
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
Analyst Target Price
$398.05
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-09 | 2025-11-04 | 2025-08-04 | 2025-05-06 | 2025-02-12 | 2024-11-01 | 2024-07-31 | 2024-05-07 | 2024-02-06 | 2023-11-07 | 2023-08-02 | 2023-05-09 |
| Reported EPS | 4.53 | 2.5 | 2.95 | 2.25 | 4.1 | 2.93 | 2.63 | 2.21 | 3.62 | 2.84 | 2.8 | 2.49 |
| Estimated EPS | 4.51 | 2.99 | 2.94 | 2.22 | 4.03 | 2.68 | 2.56 | 2.09 | 3.55 | 2.55 | 2.59 | 2.62 |
| Surprise | 0.02 | -0.49 | 0.01 | 0.03 | 0.07 | 0.25 | 0.07 | 0.12 | 0.07 | 0.29 | 0.21 | -0.13 |
| Surprise Percentage | 0.4435% | -16.388% | 0.3401% | 1.3514% | 1.737% | 9.3284% | 2.7344% | 5.7416% | 1.9718% | 11.3725% | 8.1081% | -4.9618% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 2.31 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: WAT
2026-02-24 16:52:15
Illumina has launched TruPath Genome, a new whole-genome testing solution designed to provide rapid and accurate insights for rare disease research. This innovative workflow boasts significantly reduced hands-on time, high throughput, and improved accuracy in difficult-to-map genomic regions, with a competitive list price of $395 per genome. Early adopters and presented data highlight its capability in resolving complex genetic variants, marking a significant advancement in genetic diagnostics.
2026-02-24 11:52:15
The Next-Generation Sequencing (NGS) market is projected to grow from $14.79 billion in 2025 to $56.25 billion by 2033, driven by technological advancements, applications in genomics and personalized medicine, and increased biotech investments. NGS significantly reduces the time and cost of genomic analysis and is crucial for research in cancer and infectious diseases. Key players like Illumina, Thermo Fisher Scientific, and Roche are leading this market with ongoing innovations.
2026-02-24 07:17:00
Artisan Mid Cap Fund has increased its position in MongoDB, Inc. (MDB), a leading database software provider, citing the strength of its Atlas cloud platform and potential for growth fueled by enterprise adoption and AI-related use cases. The fund highlighted MongoDB's Q4 2025 performance, which exceeded guidance and led to a raised full-year outlook. Despite the fund's confidence, MongoDB is not among Insider Monkey's 30 Most Popular Stocks Among Hedge Funds, as they believe other AI stocks offer higher return potential in a shorter timeframe.
2026-02-24 03:52:10
Energy Recovery (ERII) is set to announce its earnings results, with analysts expecting revenue growth of 23.1% year-on-year. The company has a history of missing Wall Street's revenue estimates multiple times in the last two years. While its peers, Watts Water Technologies and Mueller Water Products, reported positive Q4 results, investor sentiment in the water infrastructure segment remains positive, with Energy Recovery shares up 12.7% over the last month.
2026-02-23 14:15:01
Waters Corporation has released its annual 10-K report, detailing a 7% increase in total net sales to $3,165 million, driven by strong customer demand across most geographies and product lines. Despite a 3% decrease in operating income due to acquisition and ERP system costs, net income saw a marginal 1% increase. The report highlights strategic initiatives like acquisitions, including Halo Labs and the BDS Business, and continued investment in new product launches and an ERP system, while also outlining challenges from integration, macroeconomic risks, and regulatory changes, including those related to AI.
2026-02-23 14:14:32
Illumina has unveiled an 18-month roadmap of advancements for its NovaSeq X system, promising an increase in data output by 40% to 35 billion reads, the introduction of Q70 quality scores for enhanced accuracy, and a 30% improvement in Whole-Genome Sequencing (WGS) run times. These updates, which include new flow cells and software enhancements, aim to make DNA sequencing faster, more accurate, and more cost-effective for a wide range of applications, especially in oncology and rare disease research. The enhancements will be rolled out to the existing global fleet of 8,901 NovaSeq X systems, setting a new standard for high-throughput sequencing.

